• Refining In Vitro Drug Response Evaluation in Cancer Researc

  2026-06-03

  Schwartz (2022) addresses the limitations of traditional in vitro drug screening by dissecting the distinct contributions of proliferative arrest and cell death in assessing anti-cancer drug efficacy. This work offers a conceptual and methodological advance, enabling more nuanced interpretation of drug responses and informing the design of future preclinical studies.

• Deep Learning of USC Mitochondria as Non-Invasive AD Biomark

  2026-06-03

  This study pioneers the use of deep learning to analyze mitochondrial morphology in urine-derived stem cells (USCs) as a non-invasive biomarker for Alzheimer’s disease (AD). By leveraging high-content fluorescence imaging and advanced convolutional neural networks, the research demonstrates robust discrimination of mitochondrial alterations in cognitively impaired individuals, offering a promising dynamic tool for early AD detection.

• SPOP Inhibition Amplifies STING-Driven Immunotherapy in Mela

  2026-06-02

  This study uncovers how SPOP, an E3 ubiquitin ligase, targets the innate immune sensor STING for degradation, dampening antitumor immunity in melanoma. Inhibiting SPOP stabilizes STING, enhances immune infiltration, and synergizes with checkpoint blockade, revealing a new molecular glue mechanism with translational implications.

• Mubritinib (TAK 165): Rethinking Mitochondrial Targeting in

  2026-06-02

  This article explores Mubritinib (TAK 165) as a next-generation tool for translational cancer research. Integrating new mechanistic insights, recent clinical findings, and practical guidance, it offers strategic recommendations for researchers navigating the evolving landscape of mitochondrial-targeted therapies beyond HER2 inhibition.

• Metabolic Intervention Enhances Ferroptosis and Cuproptosis

  2026-06-01

  This study presents a nanosystem-based metabolic intervention that synchronously sensitizes tumor cells to ferroptosis and cuproptosis by targeting glycolysis and NAD+ metabolism. The approach not only amplifies regulated cell death but also boosts anti-tumor immunity, providing a robust framework for future cancer therapies involving multi-pathway cell death modulation.

• Perifosine (KRX-0401): Advanced Insights into Akt Inhibition

  2026-06-01

  Discover how Perifosine (KRX-0401) enables precise Akt inhibition for apoptosis research, integrating mechanistic depth and translational relevance. This article offers a unique perspective on experimental design and practical assay decisions for apoptosis and radiation sensitization.

• Anti-HMGB1 Rabbit Monoclonal Antibody: Technical Application

  2026-05-31

  The Anti-HMGB1 Rabbit Monoclonal Antibody (SKU MA3057) is designed for research workflows requiring specific detection of HMGB1 protein in human, mouse, and rat samples by Western blot, immunohistochemistry, or flow cytometry. It is not intended for diagnostic or therapeutic use, and users should follow protocol parameters and workflow best practices for reliable results.

• Comparative In Vitro Activity of Temafloxacin vs. Older Quin

  2026-05-30

  This article analyzes the pivotal findings of Hardy's 1991 study, which systematically compared the in vitro efficacy of temafloxacin—a newer fluoroquinolone—against a spectrum of gram-negative bacterial pathogens. It contextualizes the study's innovations relative to classic quinolone antibiotics like cinoxacin, highlighting methodological advancements and implications for antimicrobial research.

• Alpha-Ketoglutarate in Metabolic Reprogramming Research Work

  2026-05-29

  Alpha-ketoglutarate (α-KGA) offers unique leverage in dissecting cellular metabolism, immune modulation, and enzyme system behaviors in oncology and immunology research. This guide delivers actionable protocol strategies, troubleshooting insights, and workflow enhancements to maximize α-KGA’s impact in metabolic reprogramming and enzyme studies.

• Suhuang Capsule Inhibits NLRP3 Inflammasome via ER Stress Su

  2026-05-29

  This study reveals that Suhuang antitussive capsule improves pulmonary function in cough variant asthma (CVA) by attenuating endoplasmic reticulum (ER) stress and inhibiting NLRP3 inflammasome activation. The work delineates the mechanistic role of the RIP1-RIP3-DRP1 pathway and provides a pharmacological basis for targeting mitochondrial dynamics in pulmonary inflammation.

• Tunicamycin: Applied Workflows for N-Glycosylation Inhibitio

  2026-05-28

  Tunicamycin stands out as a robust N-glycosylation inhibitor for dissecting ER stress and inflammatory pathways in both in vitro and in vivo models. This article guides researchers through experimental setups, troubleshooting, and the latest comparative insights, drawing on key findings and scenario-driven resources to optimize reproducibility and data clarity.

• Enhancing Peptide Synthesis with HOBt (1-Hydroxybenzotriazol

  2026-05-28

  This article presents evidence-based strategies for biomedical and peptide researchers facing challenges in amide bond formation, highlighting the role of HOBt (1-Hydroxybenzotriazole, SKU A7025) in minimizing epimerization and ensuring reproducibility. Real-world scenarios are analyzed, providing protocol tips, comparative vendor insights, and references to robust literature. Readers will find actionable guidance for selecting and deploying HOBt (1-Hydroxybenzotriazole) in demanding peptide synthesis workflows.

• Prochlorperazine: Multitargeted Tool for Melanoma Research

  2026-05-27

  Prochlorperazine, long recognized as a dopamine D2 receptor antagonist and antiemetic agent, is gaining new traction in melanoma research and translational oncology. This thought-leadership article dissects the mechanistic rationale, experimental validation, and translational potential of prochlorperazine, referencing both primary literature and advanced protocols. By integrating receptor pharmacology, workflow guidance, and a forward-looking perspective, we guide researchers in leveraging prochlorperazine's full scientific and clinical breadth.

• Naloxone Hydrochloride in Opioid Receptor Antagonist Researc

  2026-05-27

  Naloxone hydrochloride, a gold-standard opioid receptor antagonist, powers breakthroughs from addiction models to neural stem cell proliferation studies. Discover workflow refinements, troubleshooting tactics, and translational impact enabled by APExBIO’s high-purity reagent.

• Bacillus Strains and Media Shape γ-Glu-Cys Peptide Biosynthe

  2026-05-26

  This study systematically compares how different Bacillus strains and growth media affect the production of γ-glutamyl peptides, including gamma-Glu-Cys (γ-Glu-Cys), with implications for glutathione metabolism research and food biotechnology. The findings highlight medium composition as a dominant factor influencing peptide yield and diversity, offering practical guidance for optimizing microbial peptide synthesis workflows.

16631 records 1/1109 page Next 12345 下5页 Last page